Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter?

被引:1
作者
Fauveau, Lindsey R. R. [1 ,2 ,3 ,4 ]
Dao, Tuoc N. N. [1 ]
Wallace, Lucy B. B. [1 ]
Mamawala, Mufaddal K. K. [2 ]
Obaid, Ala [2 ]
Waddimba, Anthony C. C. [2 ,3 ]
Grant, Michael D. D. [1 ]
机构
[1] Baylor Univ, Dept Surg, Div Surg Oncol, Med Ctr, 3410 Worth St,Suite 235, Dallas, TX 75246 USA
[2] Baylor Scott & White Res Inst, 3500 Gaston Ave, Dallas, TX 75246 USA
[3] Baylor Univ, Dept Surg, Hlth Syst Sci, Med Ctr, 3500 Gaston Ave, Dallas, TX 75246 USA
[4] Ochsner Hlth, Dept Surg, Div Breast Surg Oncol, 10310 Grove Blvd, Baton Rouge, LA 70836 USA
关键词
Ductal carcinoma in situ; Breast conserving surgery; Positive margins; Reoperation; AMERICAN SOCIETY; RECURRENCE; CANCER; DCIS; RADIOTHERAPY; RATES; GUIDELINES; RADIATION; EXCISION; WOMEN;
D O I
10.1007/s10549-023-06905-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose DCIS has been shown to have a higher rate of positive margins following breast-conserving surgery (BCS) than invasive breast cancer. We aim to analyze certain factors of DCIS, specifically histologic grade and estrogen receptor (ER) status, in patients with positive surgical margins following BCS to determine if there is an association. Methods A retrospective review of our institutional patient registry was performed to identify women with DCIS and microinvasive DCIS who underwent BCS by a single surgeon from 1999 to 2021. Demographics and clinicopathologic characteristics between patients with and without positive surgical margins were compared using chi-square or Student ' s t-test. We assessed factors associated with positive margins using univariate and multivariable logistic regression. Results Of the 615 patients evaluated, there was no significant difference in demographics between the patients with and without positive surgical margins. Increasing tumor size was an independent risk factor for margin positivity (P = < 0.001). On univariate analysis both high histologic grade (P = 0.009) and negative ER status (P = < 0.001) were significantly associated with positive surgical margins. However, when adjusted in multivariable analysis, only negative ER status remained significantly associated with margin positivity (OR = 0.39 [95% CI 0.20-0.77]; P = 0.006). Conclusion The study confirms increased tumor size as a risk factor for positive surgical margins. We also demonstrated that ER negative DCIS was independently associated with a higher rate of positive margins after BCS. Given this information, we can modify our surgical approach to reduce rate of positive margins in patients with large-sized ER negative DCIS.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 32 条
[1]   Margin Re-excision and Local Recurrence in Invasive Breast Cancer: A Cost Analysis Using a Decision Tree Model [J].
Abe, Shoko E. ;
Hill, Joshua S. ;
Han, Yimei ;
Walsh, Kendall ;
Symanowski, James T. ;
Hadzikadic-Gusic, Lejla ;
Flippo-Morton, Teresa ;
Sarantou, Terry ;
Forster, Meghan ;
White, Richard L., Jr. .
JOURNAL OF SURGICAL ONCOLOGY, 2015, 112 (04) :443-448
[2]   Prediction of positive resection margins in patients with non-palpable breast cancer [J].
Barentsz, M. W. ;
Postma, E. L. ;
van Dalen, T. ;
van den Bosch, M. A. A. J. ;
Miao, H. ;
Gobardhan, P. D. ;
van den Hout, L. E. ;
Pijnappel, R. M. ;
Witkamp, A. J. ;
van Diest, P. J. ;
van Hillegersberg, R. ;
Verkooijen, H. M. .
EJSO, 2015, 41 (01) :106-112
[3]   Controversies in the Treatment of Ductal Carcinoma in Situ [J].
Barrio, Andrea V. ;
Van Zee, Kimberly J. .
ANNUAL REVIEW OF MEDICINE, VOL 68, 2017, 68 :197-211
[4]   Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-Year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group [J].
Bijker, Nina ;
Meijnen, Philip ;
Peterse, Johannes L. ;
Bogaerts, Jan ;
Van Hoorebeeck, Irene ;
Julien, Jean-Pierre ;
Gennaro, Massimiliano ;
Rouanet, Philippe ;
Avril, Antoine ;
Fentiman, Ian S. ;
Bartelink, Harry ;
Rutgers, Emiel J. Th. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (21) :3381-3387
[5]   Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial [J].
Cuzick, Jack ;
Sestak, Ivana ;
Pinder, Sarah E. ;
Ellis, Ian O. ;
Forsyth, Sharon ;
Bundred, Nigel J. ;
Forbes, John F. ;
Bishop, Hugh ;
Fentiman, Ian S. ;
George, William D. .
LANCET ONCOLOGY, 2011, 12 (01) :21-29
[6]   Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial [J].
Donker, Mila ;
Litiere, Saskia ;
Werutsky, Gustavo ;
Julien, Jean-Pierre ;
Fentiman, Ian S. ;
Agresti, Roberto ;
Rouanet, Philippe ;
de lara, Christine Tunon ;
Bartelink, Harry ;
Duez, Nicole ;
Rutgers, Emiel J. T. ;
Bijker, Nina .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) :4054-4059
[7]  
Ernster VL, 2002, JNCI-J NATL CANCER I, V94, P1546
[8]   Pathologic variables predictive of breast events in patients with ductal carcinoma in situ [J].
Fisher, Edwin R. ;
Land, Stephanie R. ;
Saad, Reda S. ;
Fisher, Bernard ;
Wickerham, D. Lawrence ;
Wang, Meihua ;
Costantino, Joseph P. ;
Wolmark, Norman .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 128 (01) :86-91
[9]  
FISHER ER, 1995, CANCER-AM CANCER SOC, V75, P1310, DOI 10.1002/1097-0142(19950315)75:6<1310::AID-CNCR2820750613>3.0.CO
[10]  
2-G